Loomis, Sayles & Company
OGN icon

Loomis, Sayles & Company’s Organon & Co OGN Stock Holding History

Loomis, Sayles & Company’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-614
Closed -$9K – 889
2023
Q4 		$9K Buy
614
+207
+51% +$2.82K ﹤0.01% 809
2023
Q3 		$7K Buy
407
+177
+77% +$3.69K ﹤0.01% 868
2023
Q2 		$5K Sell
230
-175
-43% -$3.8K ﹤0.01% 855
2023
Q1 		$10K Buy
+405
New +$10.9K ﹤0.01% 852
2022
Q4 		– Sell
-46
Closed -$1K – 950
2022
Q3 		$1K Sell
46
-284
-86% -$8.57K ﹤0.01% 917
2022
Q2 		$11K Sell
330
-262
-44% -$9.18K ﹤0.01% 653
2022
Q1 		$21K Buy
592
+352
+147% +$12K ﹤0.01% 630
2021
Q4 		$7K Sell
240
-5
-2% -$163 ﹤0.01% 756
2021
Q3 		$8K Sell
245
-52,786
-100% -$1.69M ﹤0.01% 867
2021
Q2 		$1.6M Buy
+53,031
New +$1.75M ﹤0.01% 484

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Loomis, Sayles & Company's OGN Position: Q1 2024 in Review

Loomis, Sayles & Company sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 614 shares — an estimated $9K sold.

Loomis, Sayles & Company first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $1.6M in Q2 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Loomis, Sayles & Company reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 614 Organon & Co shares in Q1 2024, an estimated $9K.
  • Loomis, Sayles & Company first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Loomis, Sayles & Company's Organon & Co position peaked at $1.6M in Q2 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.